NM_002495.4:c.355G>C
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_002495.4(NDUFS4):c.355G>C(p.Asp119His) variant causes a missense change. The variant allele was found at a frequency of 0.00000205 in 1,460,850 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_002495.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NDUFS4 | NM_002495.4 | c.355G>C | p.Asp119His | missense_variant | Exon 4 of 5 | ENST00000296684.10 | NP_002486.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251172Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135768
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1460850Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 726794
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Mitochondrial complex I deficiency, nuclear type 1 Pathogenic:2
- -
Inheritance: The variant was identified in the Homozygous state in the sample. Frequency: The variant is rare, observed in 2 alleles out of 251,172 (0.001%) in the gnomAD reference population dataset. (PM2_support) Allelic data: This variant was previously reported in trans with a pathogenic variant or in a homozygous state (PMID: 31386302‚ 31292494, Clalit). (PM3_strong) Prediction tools: REVEL predicts a deleterious effect on the gene or gene product (score 0.88). (PP3_moderate) Phenotype: The patient's phenotype or family history is highly specific for a disease with a single genetic etiology. (PP4) Clinical evidence: This variant has previously been described in ClinVar (VCV587577) with the following classifications: LP (5). Sources: This variant has been previously described in several publications (see PMID: 19364667, 31386302, and 31292494). Notably, these studies separately described two patients with the clinical diagnosis of Leigh syndrome who were carriers of this variant either in the heterozygous or homozygous state. Sage-Schwaede, et al., moreover discussed a potential pharmacological intervention. Taken together, we interpret this variant as pathogenic (pm2_support, pm3_strong, pp3_moderate, pp4). -
Leigh syndrome Pathogenic:1
- -
Mitochondrial complex I deficiency Pathogenic:1
- -
not provided Pathogenic:1
This sequence change replaces aspartic acid, which is acidic and polar, with histidine, which is basic and polar, at codon 119 of the NDUFS4 protein (p.Asp119His). This variant is present in population databases (rs747359752, gnomAD 0.01%). This missense change has been observed in individual(s) with Leigh syndrome (PMID: 19364667, 31386302). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 587577). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects NDUFS4 function (PMID: 22326555). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at